JPWO2020051051A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020051051A5
JPWO2020051051A5 JP2021512444A JP2021512444A JPWO2020051051A5 JP WO2020051051 A5 JPWO2020051051 A5 JP WO2020051051A5 JP 2021512444 A JP2021512444 A JP 2021512444A JP 2021512444 A JP2021512444 A JP 2021512444A JP WO2020051051 A5 JPWO2020051051 A5 JP WO2020051051A5
Authority
JP
Japan
Prior art keywords
composition
amino acid
spare
acid residue
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512444A
Other languages
English (en)
Japanese (ja)
Other versions
JP7589143B2 (ja
JP2021536461A5 (https=
JP2021536461A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/048698 external-priority patent/WO2020051051A1/en
Publication of JP2021536461A publication Critical patent/JP2021536461A/ja
Publication of JPWO2020051051A5 publication Critical patent/JPWO2020051051A5/ja
Publication of JP2021536461A5 publication Critical patent/JP2021536461A5/ja
Priority to JP2024091680A priority Critical patent/JP2024113090A/ja
Application granted granted Critical
Publication of JP7589143B2 publication Critical patent/JP7589143B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021512444A 2018-09-05 2019-08-29 神経可塑性を誘導するための方法および組成物 Active JP7589143B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024091680A JP2024113090A (ja) 2018-09-05 2024-06-05 神経可塑性を誘導するための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862727420P 2018-09-05 2018-09-05
US62/727,420 2018-09-05
PCT/US2019/048698 WO2020051051A1 (en) 2018-09-05 2019-08-29 Methods and compositions for inducing neural plasticity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024091680A Division JP2024113090A (ja) 2018-09-05 2024-06-05 神経可塑性を誘導するための方法および組成物

Publications (4)

Publication Number Publication Date
JP2021536461A JP2021536461A (ja) 2021-12-27
JPWO2020051051A5 true JPWO2020051051A5 (https=) 2022-09-06
JP2021536461A5 JP2021536461A5 (https=) 2022-09-06
JP7589143B2 JP7589143B2 (ja) 2024-11-25

Family

ID=69722599

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021512444A Active JP7589143B2 (ja) 2018-09-05 2019-08-29 神経可塑性を誘導するための方法および組成物
JP2024091680A Pending JP2024113090A (ja) 2018-09-05 2024-06-05 神経可塑性を誘導するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024091680A Pending JP2024113090A (ja) 2018-09-05 2024-06-05 神経可塑性を誘導するための方法および組成物

Country Status (8)

Country Link
US (2) US12138300B2 (https=)
EP (1) EP3846838A4 (https=)
JP (2) JP7589143B2 (https=)
KR (1) KR102919967B1 (https=)
CN (1) CN113260373B (https=)
AU (1) AU2019334965B2 (https=)
CA (1) CA3111512A1 (https=)
WO (1) WO2020051051A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025092748A1 (zh) * 2023-11-01 2025-05-08 拜西欧斯(北京)生物技术有限公司 多肽衍生物、其药物组合物及其用途
WO2025169981A1 (ja) * 2024-02-07 2025-08-14 第一工業製薬株式会社 脳機能を改善するための環状ペプチド誘導体組成物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945108A1 (de) 1979-11-08 1981-05-21 Interatom Internationale Atomreaktorbau Gmbh, 5060 Bergisch Gladbach Faltenbalgkompensator
FR2641360B1 (fr) 1988-12-29 1991-02-22 Commissariat Energie Atomique Compensateur de dilatation monte entre deux tuyauteries
US5804604A (en) * 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
WO1995009656A1 (en) 1993-10-01 1995-04-13 New York University Novel receptor-type phosphotyrosine phosphatase-sigma
DE60023920T2 (de) 1999-08-27 2006-07-20 Sugen, Inc., South San Francisco Phosphatmimetika und Verfahren zur Behandlung mit Phosphataseinhibitoren HIBITOREN
EP1305333A4 (en) 2000-07-31 2006-04-12 Active Motif PEPTIDE-MEDIATED DELIVERY OF MOLECULES IN CELLS
WO2002083182A2 (en) 2001-04-12 2002-10-24 Mcgill University The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification
US7829087B2 (en) 2001-07-09 2010-11-09 Elan Pharmaceuticals, Inc. Methods of treating cognitive impairment
KR100814109B1 (ko) 2006-01-09 2008-03-14 한국생명공학연구원 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
US20090202544A1 (en) 2006-02-02 2009-08-13 The Trustees Of Columbia University In The City Of New York Methods of Treating Diseases by Targeting Silt3
KR100999043B1 (ko) 2007-12-04 2010-12-09 한국생명공학연구원 융합 단백질을 사용하지 않는 인간 단백질 타이로신탈인산화 효소의 활성 도메인 대량 생산 방법
WO2010129681A1 (en) 2009-05-05 2010-11-11 Van Andel Research Institute Methods for treating autophagy-related disorders
WO2010146058A1 (en) 2009-06-15 2010-12-23 Vib Vzw Bace1 inhibitory antibodies
WO2011022462A2 (en) 2009-08-18 2011-02-24 President And Fellows Of Harvard College Neural regeneration
WO2012019086A2 (en) 2010-08-06 2012-02-09 The University Of North Carolina At Chapel Hill Inhibition of lar phosphatase to enhance therapeutic angiogenesis
US9744188B2 (en) 2011-02-18 2017-08-29 President And Fellows Of Harvard College Methods of promoting neuronal outgrowth by gypican 2 that binds to receptor protein tyrosine phosphatase sigma
AU2013235422B2 (en) 2012-03-19 2016-12-15 Buck Institute For Research On Aging APP specific BACE inhibitors (ASBIs) and uses thereof
US9937242B2 (en) 2012-04-09 2018-04-10 Case Western Reserve University Compositions and methods for inhibiting the activity of LAR family phosphatases
US20150084328A1 (en) 2013-09-24 2015-03-26 Witzenmann Gmbh Compensator arrangement

Similar Documents

Publication Publication Date Title
RU2412721C2 (ru) Применение ремиелинизирующего средства для стимуляции нервных клеток при демиелинизирующем заболевании
McKerracher Spinal cord repair: strategies to promote axon regeneration
JP2021536461A5 (https=)
Ziemka-Nalecz et al. Neuroprotective effects of histone deacetylase inhibitors in brain ischemia
JP2021526823A5 (https=)
US9809823B2 (en) DNA aptamers for promoting remyelination
RU2018142917A (ru) Способы и композиции для лечения рассеянного склероза и связанных с ним заболеваний
JPWO2020063488A5 (https=)
Jasmin et al. Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain
JP2021531834A5 (https=)
JPWO2020051051A5 (https=)
CA2342770A1 (en) Ly6h gene
JP2021534206A5 (https=)
JP2010509345A5 (https=)
Xiong et al. Effect of sutellarin on neurogenesis in neonatal hypoxia–ischemia rat model: potential mechanisms of action
JPWO2008038599A1 (ja) 軸索再生促進剤
CA2506481A1 (en) Method of treatment of conditions by administration of streptolysin o
JP2017524727A5 (https=)
CN106928322A (zh) 一种具有抗脑缺血作用的融合多肽及其应用
JP2025060836A5 (https=)
Zhang et al. Electro-stimulation of cerebellar fastigial nucleus (FNS) improves axonal regeneration
FI4321216T3 (fi) Koostumuksia ja menetelmiä tulehduksellisten neurologisten sairauksien hoitamiseksi
JP2022121359A5 (https=)
JP2021518392A5 (https=)
JPWO2020123663A5 (https=)